Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Nicholas Wald

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Physiology

Procedures

Chemicals & Drugs

Phenomena

False Positive Reactions

Concepts & Ideas

Activities & Behaviors

Smoking

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
36
Morris, Joan
30
Law, Malcolm
27
Hackshaw, Allan
16
Huttly, Wayne
13
Watt, HC
11
Bestwick, Jonathan
7
Rudnicka, Alicja
6
Watt, Hilary
4
Wald, David
3
Rish, Simon
3
Rodeck, Charles
3
Alberman, Eva
3
Haddow, James
3
Huang, T
3
Craig, Wendy

Sign-in to see all Coauthors

Publications

TOP 3
Law M R; Morris J K; Wald N J
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.
Wald N J; Huttly W J; Murphy K W; Ali K; Bestwick J P; Rodeck C H
Antenatal screening for Down's syndrome using the Integrated test at two London hospitals.
Wald Nicholas J; Morris Joan K; Walker Kate; Simpson John M
Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Nicholas Wald (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Law M R; Morris J K; Wald N J
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.
BMJ (Clinical research ed.) 2009;338():b1665.
2009: Wald N J; Huttly W J; Murphy K W; Ali K; Bestwick J P; Rodeck C H
Antenatal screening for Down's syndrome using the Integrated test at two London hospitals.
Journal of medical screening 2009;16(1):7-10.
2008: Wald Nicholas J; Morris Joan K; Walker Kate; Simpson John M
Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis.
Prenatal diagnosis 2008;28(12):1094-104.
2008: Wald David S; Law Malcolm; Mills Sarah; Bestwick Jonathan P; Morris Joan K; Wald Nicholas J
A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Clinical therapeutics 2008;30(11):2030-9.
2008: Wald Nicholas J; Bestwick Jonathan P; Canick Jacob A
Contingent screening for Down syndrome.
Prenatal diagnosis 2008;28(8):781; author reply 782.
2008: Wald Nicholas J; Morris Joan K; Young Neville J; Wald David S
Meta-analysis audit trail.
Lancet 2008;371(9612):558.
2008: Morris J K; Bestwick J; Wald N J
Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.
Journal of medical screening 2008;15(2):55-61.
2007: Wald David S; Bestwick Jonathan P; Wald Nicholas J
Familial hypercholesterolaemia: screening needs a fresh approach.
BMJ (Clinical research ed.) 2007;335(7628):1007-8.
2007: Wald David S; Bestwick Jonathan P; Wald Nicholas J
Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.
BMJ (Clinical research ed.) 2007;335(7620):599.
2007: Wald Nicholas J; Oakley Godfrey P
Should folic acid fortification be mandatory? Yes.
BMJ (Clinical research ed.) 2007;334(7606):1252.
2007: Wald N J; Bestwick J P; Barnes I M; Kellner L H
Anomalous marker patterns in Down syndrome screening.
Prenatal diagnosis 2007;27(2):185-6.
2007: Wald Nicholas J; Bestwick Jonathan P; Morris Joan K
Truncation limits for CT marker ratios in prenatal screening for Down syndrome.
Prenatal diagnosis 2007;27(2):187-8.
2007: Wald N J
Screening: a step too far. A matter of concern.
Journal of medical screening 2007;14(4):163-4.
2007: Morris J K; Wald N J
The effect of correlations between screening markers on screening performance.
Journal of medical screening 2007;14(3):151-7.
2007: Morris J K; Wald N J
Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004.
Journal of medical screening 2007;14(2):55-9.
2007: Morris J K; Wald N J
Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.
Journal of medical screening 2007;14(1):5-7.
2006: Huttly Wayne J; Morris Joan K; Bestwick Jonathan P; Wald Nicholas J; Murphy Karl; Pandya Pranav P
Three stage contingent screening for Down syndrome.
Prenatal diagnosis 2006;26(12):1183; author reply 1184.
2006: Wald David S; Wald Nicholas J; Morris Joan K; Law Malcolm
Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence.
BMJ (Clinical research ed.) 2006;333(7578):1114-7.
2006: Wald Nicholas J; Rudnicka Alicja R; Bestwick Jonathan P
Sequential and contingent prenatal screening for Down syndrome.
Prenatal diagnosis 2006;26(9):769-77.
2006: Morris J K; George L M; Wu T; Wald N J
Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies.
British journal of cancer 2006;95(1):112-7.
2006: Wald Nicholas J; Bestwick Jonathan P; Morris Joan K
Cross-trimester marker ratios in prenatal screening for Down syndrome.
Prenatal diagnosis 2006;26(6):514-23.
2006: Wald Nicholas J; Morris Joan K; Ibison Judith; Wu Tiesheng; George Lynne M
Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
Prenatal diagnosis 2006;26(6):559-64.
2006: Wald Nicholas J; Barnes Isobel M; Birger Ruthie; Huttly Wayne
Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.
Prenatal diagnosis 2006;26(6):539-44.
2006: Wald N J; Bestwick J P; Huttly W J; Morris J K; George L M
Validation plots in antenatal screening for Down's syndrome.
Journal of medical screening 2006;13(4):166-71.
2005: Wald Nicholas J; Rish Simon
Prenatal screening for Down syndrome and neural tube defects in twin pregnancies.
Prenatal diagnosis 2005;25(9):740-5.
2005: Wald N J; Rodeck C; Hackshaw A K; Rudnicka A
SURUSS in perspective.
Seminars in perinatology 2005;29(4):225-35.
2005: Wald Nicholas J; Morris Joan K; Rish Simon
The efficacy of combining several risk factors as a screening test.
Journal of medical screening 2005;12(4):197-201.
2005: Morris J K; Wald N J
Graphical presentation of distributions of risk in screening.
Journal of medical screening 2005;12(3):155-60.
2004: Wald Nicholas J; Huttly Wayne J; Rudnicka Alicja R
Recurrent false-positives in AFP screening for open neural tube defects.
Prenatal diagnosis 2004;24(12):1018-9.
2004: Huttly Wayne; Rudnicka Alicja; Wald Nicholas J
Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
Prenatal diagnosis 2004;24(10):804-7.
2004: Morris J K; Law M R; Wald N J
Is cascade testing a sensible method of screening a population for autosomal recessive disorders?
American journal of medical genetics. Part A 2004;128A(3):271-5.
2004: Wald Nicholas J; Huttly Wayne J; Rudnicka Alicja R
Prenatal screening for Down syndrome: the problem of recurrent false-positives.
Prenatal diagnosis 2004;24(5):389-92.
2004: Wald Nicholas J
Folic acid and the prevention of neural-tube defects.
The New England journal of medicine 2004;350(2):101-3.
2004: Law M R; Wald N J; Morris J K
The performance of blood pressure and other cardiovascular risk factors as screening tests for ischaemic heart disease and stroke.
Journal of medical screening 2004;11(1):3-7.
2003: Wald Nicholas J; Morris Joan K
Teleoanalysis: combining data from different types of study.
BMJ (Clinical research ed.) 2003;327(7415):616-8.
2003: Law Malcolm R; Wald Nicholas J
Environmental tobacco smoke and ischemic heart disease.
Progress in cardiovascular diseases 2003;46(1):31-8.
2003: Wald Nicholas J; Rish Simon; Hackshaw Allan K
Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies.
Prenatal diagnosis 2003;23(7):588-92.
2003: Law M R; Wald N J; Morris J K; Jordan R E
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.
BMJ (Clinical research ed.) 2003;326(7404):1427.
2003: Law M R; Wald N J; Rudnicka A R
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.
BMJ (Clinical research ed.) 2003;326(7404):1423.
2003: Wald N J; Law M R
A strategy to reduce cardiovascular disease by more than 80%.
BMJ (Clinical research ed.) 2003;326(7404):1419.
2003: Wald N J; Morris J K; Rodeck C H; Haddow J E; Palomaki G E
Cystic fibrosis: selecting the prenatal screening strategy of choice.
Prenatal diagnosis 2003;23(6):474-83.
2003: Huang T; Alberman E; Watt H C; Wald N J
Using Down syndrome serum screening results to predict low birthweight.
Prenatal diagnosis 2003;23(5):420-6.
2003: Wald Nicholas J; Huttly Wayne J; Hackshaw Allan K
Antenatal screening for Down's syndrome with the quadruple test.
Lancet 2003;361(9360):835-6.
2003: Morris J K; Wald N J; Mutton D E; Alberman E
Comparison of models of maternal age-specific risk for Down syndrome live births.
Prenatal diagnosis 2003;23(3):252-8.
2003: Wald N J; Rodeck C; Hackshaw A K; Walters J; Chitty L; Mackinson A M
First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).
Journal of medical screening 2003;10(2):56-104.
2003: Wald N J; Rodeck C; Hackshaw A K; Walters J; Chitty L; Mackinson A M;
First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).
Health technology assessment (Winchester, England) 2003;7(11):1-77.
2002: Law Malcolm R; Watt Hilary C; Wald Nicholas J
The underlying risk of death after myocardial infarction in the absence of treatment.
Archives of internal medicine 2002;162(21):2405-10.
2002: Wald Nicholas J; Huttly Wayne; Hackshaw Allan K
Antenatal screening policies for Down's syndrome. Audit of Down's syndrome screening is not valid.
BMJ (Clinical research ed.) 2002;325(7371):1034; author reply 1034.
2002: Rudnicka Alicja R; Wald Nicholas J; Huttly Wayne; Hackshaw Allan K
Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.
Prenatal diagnosis 2002;22(10):893-7.
2002: Wald Nicholas J; Law Malcolm; Haddow James E; Craig Wendy Y
Apolipoprotiens and prediction of fatal myocardial infarction.
Lancet 2002;359(9320):1864.
2001: Wald N J; Law M R; Morris J K; Wald D S
Quantifying the effect of folic acid.
Lancet 2001;358(9298):2069-73.
2001: Hackshaw A K; Wald N J
Inaccurate estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening.
Prenatal diagnosis 2001;21(9):741-6.
2001: Hackshaw A K; Wald N J
Assessment of the value of reporting partial screening results in prenatal screening for Down syndrome.
Prenatal diagnosis 2001;21(9):737-40.
2001: Wald D S; Bishop L; Wald N J; Law M; Hennessy E; Weir D; McPartlin J; Scott J
Randomized trial of folic acid supplementation and serum homocysteine levels.
Archives of internal medicine 2001;161(5):695-700.
2001: Wald N J; Morris J K
Multiple marker second trimester serum screening for pre-eclampsia.
Journal of medical screening 2001;8(2):65-8.
2001: Wald N J
Folic acid and neural tube defects.
Bibliotheca nutritio et dieta 2001;(55):22-33.
2000: Wald N J; Hackshaw A K; Huttly W
Screening for Down's syndrome. Serum screening programmes are effective and safe.
BMJ (Clinical research ed.) 2000;321(7263):763-4; author reply 764-5.
2000: Wald N J; Law M R; Morris J K; Zhou X; Wong Y; Ward M E
Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study.
BMJ (Clinical research ed.) 2000;321(7255):204-7.
2000: Wald N J; Hackshaw A K; Watt H
Nuchal translucency and trisomy 18.
Prenatal diagnosis 2000;20(4):353-4.
2000: Wald N J; Watt H C; George L; Knekt P; Helzlsouer K J; Tuomilehto J
Adding free to total prostate-specific antigen levels in trials of prostate cancer screening.
British journal of cancer 2000;82(3):731-6.
2000: Wald N J; Hackshaw A K; George L M
Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down's syndrome.
Journal of medical screening 2000;7(2):74-7.
1999: Wald N J; White N; Morris J K; Huttly W J; Canick J A
Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening.
British journal of obstetrics and gynaecology 1999;106(12):1304-6.
1999: Wald N J; Hackshaw A K; Watt H
Nuchal translucency and trisomy 18.
Prenatal diagnosis 1999;19(10):995-6.
1999: Watt H C; Wald N J; Huttly W J
Inhibin-A regression.
Prenatal diagnosis 1999;19(9):893-4.
1999: Wald N J; Watt H C; Hackshaw A K
Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters.
The New England journal of medicine 1999;341(7):461-7.
1999: Wald N J; Hackshaw A K; Diamandis E P; Melegos D N
Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy. International Prenatal Screening Research Group.
Prenatal diagnosis 1999;19(7):674-6.
1999: Law M R; Wald N J
Homocysteine and ischaemic heart disease.
Haematologica 1999;84 Suppl EHA-4():57-60.
1999: Wald N J; Watt H C; Norgaard-Pedersen B; Christiansen M
SP1 in pregnancies with Down syndrome in the first trimester of pregnancy. International Prenatal Screening Research Group.
Prenatal diagnosis 1999;19(6):517-20.
1999: Morris J K; Wald N J; Watt H C
Fetal loss in Down syndrome pregnancies.
Prenatal diagnosis 1999;19(2):142-5.
1999: Wald N J; Watt H C
The target plot: a new way of displaying the performance of a screening test.
Journal of medical screening 1999;6(4):195-9.
1999: Morris J K; Wald N J
Quantifying the decline in the birth prevalence of neural tube defects in England and Wales.
Journal of medical screening 1999;6(4):182-5.
1999: Wald N J; Dormandy E R
Reporting of screening results.
Journal of medical screening 1999;6(3):117-8.
1999: Law M R; Morris J K; Wald N J
The importance of age in screening for cancer.
Journal of medical screening 1999;6(1):16-20.
1998: Watt H C; Law M R; Wald N J; Craig W Y; Ledue T B; Haddow J E
Serum triglyceride: a possible risk factor for ruptured abdominal aortic aneurysm.
International journal of epidemiology 1998;27(6):949-52.
1998: Watt H C; Wald N J; Huttly W J
The pattern of maternal serum inhibin-A concentrations in the second trimester of pregnancy.
Prenatal diagnosis 1998;18(8):846-8.
1998: Watt H C; Wald N J
Alternative methods of maternal weight adjustment in maternal serum screening for Down syndrome and neural tube defects.
Prenatal diagnosis 1998;18(8):842-5.
1998: Wald N J; Watt H C; Law M R; Weir D G; McPartlin J; Scott J M
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.
Archives of internal medicine 1998;158(8):862-7.
1998: Wald N J; Watt H C; Haddow J E; Knight G J
Screening for Down syndrome at 14 weeks of pregnancy.
Prenatal diagnosis 1998;18(3):291-3.
1998: Wald N J; Kennard A; Hackshaw A; McGuire A
Antenatal screening for Down's syndrome.
Health technology assessment (Winchester, England) 1998;2(1):i-iv, 1-112.
1997: Wald N J; Law M R; Morris J K; Bagnall A M
Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study.
BMJ (Clinical research ed.) 1997;315(7117):1199-201.
1997: Hackshaw A K; Law M R; Wald N J
The accumulated evidence on lung cancer and environmental tobacco smoke.
BMJ (Clinical research ed.) 1997;315(7114):980-8.
1997: Law M R; Morris J K; Wald N J
Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence.
BMJ (Clinical research ed.) 1997;315(7114):973-80.
1997: Wald N J; Hackshaw A K
Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.
Prenatal diagnosis 1997;17(9):821-9.
1997: Huang T; Watt H C; Wald N J
The effect of differences in the distribution of maternal age in England and Wales on the performance of prenatal screening for Down's syndrome.
Prenatal diagnosis 1997;17(7):615-21.
1997: Wald N J; Watt H C
Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases.
BMJ (Clinical research ed.) 1997;314(7098):1860-3.
1997: Wald N J; Kennard A; Hackshaw A; McGuire A
Antenatal screening for Down's syndrome.
Journal of medical screening 1997;4(4):181-246.
1997: Huang T; Watt H C; Wald N J; Morris J K; Mutton D; Alberman E
Reliability of statistics on Down's syndrome notifications.
Journal of medical screening 1997;4(2):95-7.
1997: Law M R; Morris J K; Watt H C; Wald N J
The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer.
British journal of cancer 1997;75(11):1690-3.
1996: Watt H C; Wald N J; George L
Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome.
Prenatal diagnosis 1996;16(10):927-9.
1996: Wald N J; Watt H C; George L
Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
Prenatal diagnosis 1996;16(10):923-6.
1996: Wald N J; Watt H C
Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Prenatal diagnosis 1996;16(8):699-703.
1996: Watt H C; Wald N J; Smith D; Kennard A; Densem J
Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Prenatal diagnosis 1996;16(8):691-8.
1996: Wald N J; George L; Smith D; Densem J W; Petterson K
Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
British journal of obstetrics and gynaecology 1996;103(5):407-12.
1996: Wald N J; Hackshaw A D; Stone R; Sourial N A
Blood folic acid and vitamin B12 in relation to neural tube defects.
British journal of obstetrics and gynaecology 1996;103(4):319-24.
1996: Wald N J; Densem J W; George L; Muttukrishna S; Knight P G
Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
Prenatal diagnosis 1996;16(2):143-53.
1996: Wald N J; Huttly W; Wald K; Kennard A
Down's syndrome screening in UK.
Lancet 1996;347(8997):330.
1996: Wald N J; Hackshaw A K
Cigarette smoking: an epidemiological overview.
British medical bulletin 1996;52(1):3-11.
1996: Wald N J; Hackshaw A K; Huttly W; Kennard A
Empirical validation of risk screening for Down's syndrome.
Journal of medical screening 1996;3(4):185-7.
1995: Hackshaw A K; Densem J; Wald N J
Repeat maternal serum testing for Down's syndrome screening using multiple markers with special reference to free alpha and free beta-hCG.
Prenatal diagnosis 1995;15(12):1125-30.
1995: Wald N J; Kennard A; Hackshaw A K
First trimester serum screening for Down's syndrome.
Prenatal diagnosis 1995;15(13):1227-40.
1995: Tang J L; Morris J K; Wald N J; Hole D; Shipley M; Tunstall-Pedoe H
Mortality in relation to tar yield of cigarettes: a prospective study of four cohorts.
BMJ (Clinical research ed.) 1995;311(7019):1530-3.
1995: Bower C; Wald N J
Vitamin B12 deficiency and the fortification of food with folic acid.
European journal of clinical nutrition 1995;49(11):787-93.
1995: Parkes C; Wald N J; Murphy P; George L; Watt H C; Kirby R; Knekt P; Helzlsouer K J; Tuomilehto J
Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer.
BMJ (Clinical research ed.) 1995;311(7016):1340-3.
1995: Frost C; Fullerton F M; Stephen A M; Stone R; Nicolaides-Bouman A; Densem J; Wald N J; Semmence A
The tar reduction study: randomised trial of the effect of cigarette tar yield reduction on compensatory smoking.
Thorax 1995;50(10):1038-43.
1995: Wald N J
Folic acid and the prevention of neural tube defects: the need for public health action.
Bibliotheca nutritio et dieta 1995;(52):56-65.
1995: Hackshaw A K; Kennard A; Wald N J
Detection of pregnancies with trisomy 18 in screening programmes for Down's syndrome.
Journal of medical screening 1995;2(4):228-9.
1994: Parkes C A; Smith D; Wald N J; Bourne T H
Feasibility study of a randomised trial of ovarian cancer screening among the general population.
Journal of medical screening 1994;1(4):209-14.
1994: Wald N J; Hackshaw A; Chamberlain J
The efficacy and safety of periodic mammographic breast cancer screening: summary of report of the European Society of Mastology.
Clinical radiology 1994;49(9):592-3.
1994: Wald N J; Densem J W; Cheng R; Collishaw S
Maternal serum free alpha- and free beta-human chorionic gonadotrophin in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
Prenatal diagnosis 1994;14(9):835-7.
1994: Wald N J; Densem J W
Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Prenatal diagnosis 1994;14(8):717-9.
1994: Wald N J; Densem J W; Smith D; Klee G G
Four-marker serum screening for Down's syndrome.
Prenatal diagnosis 1994;14(8):707-16.
1994: Wald N J; Kennard A; Watt H C; Smith D
Value of maternal serum unconjugated oestriol measurement in prenatal screening for Down's syndrome.
Prenatal diagnosis 1994;14(8):699-706.
1994: Law M R; Wald N J
An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990.
European journal of clinical nutrition 1994;48(5):305-25.
1994: Wald N J; Watt H C
Choice of serum markers in antenatal screening for Down's syndrome.
Journal of medical screening 1994;1(2):117-20.
1994: Law M R; Morris J; Wald N J
Screening for abdominal aortic aneurysms.
Journal of medical screening 1994;1(2):110-5; discussion 115-6.
1994: Law M R; Wald N J
Disagreements are not substantial.
BMJ (Clinical research ed.) 1994;308(6935):1027-9.
1994: Wald N J; Densem J W
Maternal serum free beta-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Prenatal diagnosis 1994;14(4):319-20.
1994: Law M R; Morris J K; Wald N J; Hale A K
Serum albumin and mortality in the BUPA study. British United Provident Association.
International journal of epidemiology 1994;23(1):38-41.
1994: Law M R; Thompson S G; Wald N J
Assessing possible hazards of reducing serum cholesterol.
BMJ (Clinical research ed.) 1994;308(6925):373-9.
1994: Law M R; Wald N J; Wu T; Hackshaw A; Bailey A
Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study.
BMJ (Clinical research ed.) 1994;308(6925):363-6.
1994: Law M R; Wald N J; Thompson S G
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
BMJ (Clinical research ed.) 1994;308(6925):367-72.
1994: Wald N J; Law M; Watt H C; Wu T; Bailey A; Johnson A M; Craig W Y; Ledue T B; Haddow J E
Apolipoproteins and ischaemic heart disease: implications for screening.
Lancet 1994;343(8889):75-9.
1994: Wald N J
Folic acid and neural tube defects: the current evidence and implications for prevention.
Ciba Foundation symposium 1994;181():192-208; discussion 208-11.
1994: Wald N J; Chamberlain J; Hackshaw A
European Society of Mastology Consensus Conference on Breast Cancer screening, Paris, 4-5 February 1993: report of the Evaluation Committee.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1994;6(4):261-8.
1993: Wald N J; Hackshaw A; Stone R; Densem J
Serum alpha-fetoprotein and neural tube defects in the first trimester of pregnancy. MRC Vitamin Study Research Group.
Prenatal diagnosis 1993;13(11):1047-50.
1993: Wald N J; Smith D; Kennard A; Palomaki G E; Salonen R; Holzgreve W; Pejtsik B; Coombes E J; Mancini G; MacRae A R
Biparietal diameter and crown-rump length in fetuses with Down's syndrome: implications for antenatal serum screening for Down's syndrome.
British journal of obstetrics and gynaecology 1993;100(5):430-5.
1992: Wald N J; Kennard A; Densem J W; Cuckle H S; Chard T; Butler L
Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
BMJ (Clinical research ed.) 1992;305(6850):391-4.
1992: Cuckle H S; Densem J W; Wald N J
Detection of hydatidiform mole in maternal serum screening programmes for Down's syndrome.
British journal of obstetrics and gynaecology 1992;99(6):495-7.
1992: Wald N J; Cuckle H S; Densem J W; Kennard A; Smith D
Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
British journal of obstetrics and gynaecology 1992;99(2):144-9.
1992: Wald N J; Cuckle H S; Densem J W; Stone R B
Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
British journal of obstetrics and gynaecology 1992;99(1):51-3.
1991: Law M R; Frost C D; Wald N J
Dietary salt and blood pressure.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S37-41; discussion S47-9.
1991: Cuckle H S; Wald N J; Densem J W; Canick J; Abell K B
Second trimester amniotic fluid oestriol, dehydroepiandrosterone sulphate, and human chorionic gonadotrophin levels in Down's syndrome.
British journal of obstetrics and gynaecology 1991;98(11):1160-2.
1991: Wald N J
Couple screening for cystic fibrosis.
Lancet 1991;338(8778):1318-9.
1991: Frost C D; Law M R; Wald N J
By how much does dietary salt reduction lower blood pressure? II--Analysis of observational data within populations.
BMJ (Clinical research ed.) 1991;302(6780):815-8.
1991: Law M R; Frost C D; Wald N J
By how much does dietary salt reduction lower blood pressure? I--Analysis of observational data among populations.
BMJ (Clinical research ed.) 1991;302(6780):811-5.
1991: Law M R; Frost C D; Wald N J
By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction.
BMJ (Clinical research ed.) 1991;302(6780):819-24.
1990: Cuckle H S; Wald N J; Goodburn S F; Sneddon J; Amess J A; Dunn S C
Measurement of activity of urea resistant neutrophil alkaline phosphatase as an antenatal screening test for Down's syndrome.
BMJ (Clinical research ed.) 1990;301(6759):1024-6.
1990: Cuckle H S; Alberman E; Wald N J; Royston P; Knight G
Maternal smoking habits and Down's syndrome.
Prenatal diagnosis 1990;10(9):561-7.
1990: Rasmussen Loft A G; Nanchahal K; Cuckle H S; Wald N J; Hulten M; Leedham P; Nørgaard-Pedersen B
Amniotic fluid acetylcholinesterase in the prenatal diagnosis of open neural tube defects and abdominal wall defects: a comparison of gel electrophoresis and a monoclonal antibody immunoassay.
Prenatal diagnosis 1990;10(7):449-59.
1990: Thompson S G; Stone R; Nanchahal K; Wald N J
Relation of urinary cotinine concentrations to cigarette smoking and to exposure to other people's smoke.
Thorax 1990;45(5):356-61.
1990: Thompson S G; Barlow R D; Wald N J; Van Vunakis H
How should urinary cotinine concentrations be adjusted for urinary creatinine concentration?
Clinica chimica acta; international journal of clinical chemistry 1990;187(3):289-95.
1990: Cuckle H S; Wald N J; Densem J W; Royston P; Knight G J; Haddow J E; Palomaki G E
The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels.
British journal of obstetrics and gynaecology 1990;97(3):272-4.
1989: Cuckle H S; Wald N J; Hughes D R
Cord serum alpha-fetoprotein and maternal insulin-dependent diabetes mellitus.
British journal of obstetrics and gynaecology 1989;96(12):1450-2.
1989: Rohan T E; Frost C D; Wald N J
Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment.
BMJ (Clinical research ed.) 1989;299(6709):1198-201.
1989: Wald N J; Thompson S G; Law M R; Densem J W; Bailey A
Serum cholesterol and subsequent risk of cancer: results from the BUPA study.
British journal of cancer 1989;59(6):936-8.
1989: Cuckle H S; Wald N J; Cuckle P M
Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985.
Prenatal diagnosis 1989;9(6):393-400.
1989: Cuckle H S; Wald N J; Nanchahal K; Densem J
Repeat maternal serum alpha-fetoprotein testing in antenatal screening programmes for Down's syndrome.
British journal of obstetrics and gynaecology 1989;96(1):52-60.
1988: Wald N J; Cuckle H S; Densem J W; Nanchahal K; Royston P; Chard T; Haddow J E; Knight G J; Palomaki G E; Canick J A
Maternal serum screening for Down's syndrome in early pregnancy.
BMJ (Clinical research ed.) 1988;297(6653):883-7.
1988: Wald N J; Thompson S G; Densem J W; Boreham J; Bailey A
Serum beta-carotene and subsequent risk of cancer: results from the BUPA Study.
British journal of cancer 1988;57(4):428-33.
1988: Wald N J; Cuckle H S; Densem J W; Nanchahal K; Canick J A; Haddow J E; Knight G J; Palomaki G E
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome.
British journal of obstetrics and gynaecology 1988;95(4):334-41.
1987: Cuckle H S; Wald N J
Vaginal bleeding in pregnancies associated with fetal Down syndrome.
Prenatal diagnosis 1987;7(9):619-22.
1987: Cuckle H S; Nanchahal K; Wald N J
Maternal serum alpha-fetoprotein and ethnic origin.
British journal of obstetrics and gynaecology 1987;94(11):1111-2.
1987: Barlow R D; Stone R B; Wald N J; Puhakainen E V
The direct barbituric acid assay for nicotine metabolites in urine: a simple colorimetric test for the routine assessment of smoking status and cigarette smoke intake.
Clinica chimica acta; international journal of clinical chemistry 1987;165(1):45-52.

Sign-in to see more